Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19 | MicrobiomeTrials← Back to trialsNCT04516811
Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19
TERMINATEDPHASE3INTERVENTIONAL
Trial Details
Start: 2020-09-21Est. Completion: 2021-12-30
Enrollment target: 102 participants Locations- Universitas Hospital, Bloemfontein, Free State, South Africa
- Mitchells Plain Hospital, Cape Town, Western Cape, South Africa
Other microbiome trials you might be interested in
CancerImmunotherapy
The investigators wish to set up a pharmaco-epidemiological cohort within the Hospital Territorial Groups of the Cévenne…
Nîmes, FranceCompleted Sep 16, 2022
Long COVID
This two-year study will evaluate the feasibility and safety of an exercise + cognitive training program to improve neur…
Palo Alto, United StatesEst. completion Dec 31, 2026
Respiratory Tract InfectionSmell DisorderInfluenzaRhinosinusitisCOVID-19DepressionParosmiaHyposomiaNormosomiaAnosmia
Background:
Loss of the sense of smell can seriously affect a person's quality of life. The ability to smell can be dam…
Bethesda, United StatesCompleted Sep 30, 2029